PRQRNasdaqPharmaceutical PreparationsFiscal year ends December 31
ProQR Therapeutics N.V.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 12, 2026
$1.31+0.00 (0.00%)
Close on Oct 19, 2026
Dividends
ProQR Therapeutics has not reported a dividend
No dividend per share appears in ProQR Therapeutics's annual filings since fiscal 2014.